Home Stocks Gland Pharma Ltd

Gland Pharma Ltd

The live share price of Gland Pharma Ltd (GLAND) as on 03 May 10:24am is ₹1,686.45 from NSE/BSE.

GLAND NSE

₹1,686.45 ▼-2.08% (-35.85)

As on May 03, 2024 03:54 PM IST

How do you feel today about Gland Pharma Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

42.79

PB Ratio

3.54

Dividend Yield

-

Sector PB

5.96

Sector PE

52.69

Sector Div Yld

0.57%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹28,185 Cr

Gland Pharma is engaged in manufacturing small volume parenterals (SVPs) and contract development services.

The following charts display the financial performance of the Gland Pharma Ltd (GLAND) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Gland Pharma Ltd (GLAND), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹28,185 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	3,865 Cr	-16.42%
Operating Expense	207 Cr	+0.69%
Net Income	781 Cr	-35.54%
Net Profit Margin	20.21%	-22.86%
Earning Per Share	47	-35.76%
EBITDA	1,208 Cr	-30.29%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	3,770 Cr	+16.08%
Total Assets	8,777 Cr	+12.05%
Total Liabilities	818 Cr	+21.13%
Total Equity	7,958 Cr	+11.19%
Shares Outstanding	16.47 Cr	+0.24%
Price to Book	2.62	-65.86%
Return on Assets	9.4%	-44.41%
Return on Capital	13.34 Cr	-41.21%

Cash Flows

(INR)		Y/Y Change
Net Income	781 Cr	-35.54%
Cash from Operations	363 Cr	-53.97%
Cash from Investing	1,211 Cr	-221.2%
Cash from Financing	14 Cr	-57.25%
Net Change in Cash	1,590 Cr	-1015.73%
Free Cash Flow	140 Cr	-47.57%

Shareholding Pattern

Total Promoter Holding

57.86%

Unpledged

Foreign Institutions

3.59%

Foreign Institutions

Retail & Others

13.33%

Retail & Others

Other Parties

Other Domestic Institutions

2.22%

Insurance Firms

Others

Mutual Funds

23.01%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

40.47

1Y Return

▲56.11%

CIPLA

Cipla Ltd

PE Ratio

30.48

1Y Return

▲54.74%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

19.76

1Y Return

▲27.01%

ZYDUSLIFE

Zydus Lifesciences Ltd

PE Ratio

32.26

1Y Return

▲84.46%

Latest News

Buzzing Stocks: Paytm, IndusInd Bank, PB Fintech, ABFRL, Exide, Lupin, Gland Pharma and others

3 weeks ago on Moneycontrol

Change since news ▼-INF%

Stocks to watch: Check out the companies making headlines before the opening bell today, on April 10, 2024.

Two Entities Sell 4.9% Stake In Gland Pharma For Rs 1,411 Crore

3 weeks ago on Bloomberg Quint

Change since news ▼-INF%

Lakumi Trust and Nicomac Machinery have sold a 4.9% stake in Gland Pharma for Rs 1,411 crore through open market transactions.

Bulk deals: Promoter entity offloads stake in Gland Pharma

3 weeks ago on Moneycontrol

Change since news ▼-INF%

Nicomac Machinery Private Ltd, an entity connected to the former promoter of the company Dr Ravi Penmetsa, sold its entire 19.55 lakh shares, a 1.19 percent stake at an average price of Rs 1735.31.

FAQs on Gland Pharma Ltd

How to buy Gland Pharma Ltd stocks?

You can easily buy the stocks/shares of Gland Pharma Ltd (GLAND) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Gland Pharma Ltd?

The stock price of Gland Pharma Ltd as on 03 May 2024 is ₹1,686.45

What is the 52-week High and Low of Gland Pharma Ltd?

The 52-week high and low of Gland Pharma Ltd (GLAND) is ₹2,194 and ₹861.

What is the PE and PB ratio of Gland Pharma Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Gland Pharma Ltd are 42.79 and 3.54 respectively.

What are the peers or stocks similar to Gland Pharma Ltd?

The peers or stocks similar to Gland Pharma Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Zydus Lifesciences Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Gland Pharma Ltd belong to?

Gland Pharma Ltd (GLAND) belongs to the Pharmaceuticals sector.

What is the Market Cap of Gland Pharma Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gland Pharma Ltd (GLAND) is ₹28,185 Cr as of 03 May 2024

Can't decide whether or not to buy Gland Pharma Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.